CompoAtlas

MAX MOVE FREE

Natural health product licensed in Canada

Other names
GFU MAX MOVE FREE, GFU Max Move Free, Max Move Free
Licence holder
GFU Pharmaceutical Inc.
NPN or DIN-HM
80046709
Status
Active licence
Licence date
28 November 2013
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulfate de chondroïtine

Source : Bos taurus - cartilage

200 mgNot calculated

Non-medicinal ingredients

Huile de ricin, Poly(sorbate) 80, Hydroxypropylméthylcellulose, Croscarmellose de sodium, Dioxyde de titane, Dioxyde de silicium colloïdal, Talc, Macrogol 400, Éthyl cellulose, Cellulose microcristalline, Acide fumarique

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Comprimé2 days

Uses authorised in Canada

Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80046709

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line